HILS
Income statement / Annual
Last year (2023), Hillstream BioPharma, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Hillstream BioPharma, Inc.'s net income was -$9.32 M.
See Hillstream BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$3.56 M
|
$2.28 M
|
$1.84 M
|
$847,272.00
|
$368,732.00
|
| General & Administrative
Expenses |
$5.90 M
|
$4.60 M
|
$1.37 M
|
$671,879.00
|
$625,807.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$5.90 M
|
$4.60 M
|
$1.37 M
|
$671,879.00
|
$625,807.00
|
| Other Expenses |
$0.00 |
$0.00 |
$1.83 M |
-$362,486.00 |
-$26,458.00 |
| Operating Expenses |
$9.46 M |
$6.88 M |
$3.21 M |
$1.52 M |
$994,539.00 |
| Cost And Expenses |
$9.46 M |
$6.88 M |
$3.21 M |
$1.52 M |
$994,539.00 |
| Interest Income |
$152,631.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
-$16,505.00 |
$1.59 M |
$831,277.00 |
$246,534.00 |
$75,074.00 |
| Depreciation &
Amortization |
$167,895.00
|
$1.57 B
|
$1.83 M
|
-$73,286.00
|
$402,945.00
|
| EBITDA |
-$9.46 M
|
-$6.88 M
|
-$1.38 M
|
-$1.88 M
|
-$1.02 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$136,126.00
|
-$1.59 M
|
$1.00 M
|
-$609,020.00
|
-$101,532.00
|
| Income Before Tax |
-$9.32 M |
-$8.47 M |
-$2.21 M |
-$2.42 M |
-$1.53 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$0.00 |
$831,277.00 |
-$42,666.00 |
-$354,329.00 |
| Net Income |
-$9.32 M |
-$8.47 M |
-$3.04 M |
-$2.37 M |
-$1.17 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-7.14 |
-0.75 |
-0.3 |
-0.21 |
-0.1 |
| EPS Diluted |
-7.14 |
-0.75 |
-0.3 |
-0.21 |
-0.1 |
| Weighted Average Shares
Out |
$1.31 M
|
$11.23 M
|
$10.30 M
|
$11.23 M
|
$11.23 M
|
| Weighted Average Shares
Out Diluted |
$1.31 M
|
$11.23 M
|
$10.30 M
|
$11.23 M
|
$11.23 M
|
| Link |
|
|
|
|
|
